PolyPid Ltd (PYPD) FinancialsPYPDPolyPid Ltd

Evaluating the bottom line, PolyPid Ltd maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -243.59%, provide a clear picture of how effectively PYPD converts its operational activities into shareholder value.

In the context of the broader market, PYPD competes directly with industry leaders such as NERV and OKUR. With a market capitalization of $115.16M, it holds a leading position in the sector. When comparing efficiency, PYPD's gross margin of N/A stands against NERV's N/A and OKUR's N/A. Such benchmarking helps identify whether PolyPid Ltd is trading at a premium or discount relative to its financial performance.

PolyPid has reported a net loss reduction from $10 million to $7.8 million year-over-year, indicating improved operational efficiency. The company's cash position is also solid, with projections suggesting cash flow will extend into 2028 due to milestone payments.